Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 TU. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1827605A details a metal-free route to HIV drug precursors. Discover cost reduction in API manufacturing and reliable pharmaceutical intermediate supply.
Patent CN104844498B reveals efficient titanocene catalysis. Offers supply chain stability and cost reduction for pharmaceutical intermediate manufacturing globally.
Patent CN1187346C reveals a novel route for benzisothiazole derivatives, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Patent CN102558098A reveals a cost-effective one-pot synthesis for EGFR inhibitor intermediates, offering significant supply chain advantages for API manufacturers.
Patent CN102558098A details a one-pot synthesis for EGFR inhibitor intermediates, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Novel one-pot method replaces Pd catalysis for EGFR inhibitor intermediates, offering cost-effective scale-up and high purity for pharma supply chains.
Patent CN103857656B details enantioselective pyrrolidine synthesis offering cost reduction in agrochemical intermediate manufacturing and high-purity supply chain advantages.
Patent CN109863131A details high-purity chiral resolution. Offers supply chain reliability and cost reduction in pharma manufacturing for global partners.
Patent CN102531985A reveals a one-step Grignard route for Ezetimibe intermediates, eliminating palladium catalysts and significantly reducing manufacturing costs.
Patent CN108863969A reveals a mild Pd-catalyzed route for isoxazoles. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable methods.
Patent CN108863969A reveals mild Pd-catalyzed isoxazole synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable supply.
Novel patent CN108358783B details a safe, mild route for glutaric derivatives, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN108358783B details a safe, scalable route for 3-substituted glutaric diesters using malonic esters, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN106831551B reveals ionic liquid method for sulfonylpyridines. High yield over ninety percent. Reduced waste. Reliable supply chain for agrochemical and pharma intermediates.
Novel Heck reaction route for HIV drug intermediate IDX-899. High selectivity, mild conditions, scalable manufacturing solution for pharmaceutical intermediates.
Discover advanced synthesis routes for 3,4,5-trisubstituted isoxazoles with potent antitumor activity. Optimized for scalable API manufacturing and cost-effective procurement.
Patent CN103467228A details a mild Pd-catalyzed allyl-aryl coupling for high-purity chiral intermediates, offering significant cost reduction in API manufacturing and robust supply chain reliability.
Novel oxa-Michael cascade reaction enables high-yield production. Offers supply chain stability and cost efficiency for global pharmaceutical intermediate procurement strategies.
Advanced process for trifluoromethyltropanone cyanohydrin via patent CN1134435C. Delivers high-purity agrochemical intermediates with optimized cost reduction and supply chain reliability.
Patent CN116693389B details a mild Li2CuCl4-catalyzed route for (3E,8Z)-3,8-tetradecadienyl acetate, offering cost reduction and scalable supply chain solutions.